Recipharm

Vibalogics Cuxhaven facility Germany © Vibalogics

Vibalogics adds capacity for virotherapy manufacturing in Germany

By Jane Byrne

Vibalogics, which was recently acquired by Swedish company, Recipharm, says the completion of its expansion project at its facility in Germany boosts capacity and further enhances its flexibility, minimizing time to clinic for customers.

Pic:getty/Yakobchuk

France ramps up COVID-19 vaccine production

By Rachel Arthur

Three COVID-19 vaccine manufacturing sites are set to start production in France in the coming weeks: while the French government is seeking to boost further production with a €300m ($363m) initiative announced on Monday.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers